The company allotted 10 lakh shares to promoters at an issue price of ₹150 per share, resulting in a ₹15 Cr capital infusion. This increases promoter holding by 2%. Additionally, 5 lakh shares were allocated to employees under the ESOP scheme at ₹100 per share, aligning employee interests with company growth. No shares were allotted to institutional investors this round. This fresh equity injection strengthens the balance sheet, supporting upcoming expansion plans.